文献速递泌尿生殖MRUS

MR成像靶向前列腺活检技术检测前列腺癌的现状

The Current State of MR Imaging-targeted Biopsy Techniques for Detection of Prostate Cancer.
PubMed 文献 · Radiology · 2017-01-01

系统经直肠超声引导活检是前列腺癌组织病理诊断的标准方法,但存在无法准确定位和靶向前列腺病灶的局限。多参数MR成像能更可靠定位有临床意义的前列腺癌,MR成像靶向活检可能有助于减少假阴性结果并改善风险评估。本文综述了MR成像靶向活检平台(包括磁体腔内MR成像靶向活检和实时经直肠超声-MR成像融合活检系统)的现状、技术考量及各自的优势与挑战。

要点

  • 系统经直肠超声引导活检是前列腺癌组织病理诊断的标准方法,但无法准确定位和靶向前列腺病灶。
  • 多参数MR成像能更可靠定位有临床意义的前列腺癌,MR成像靶向活检可能减少假阴性并改善风险评估。
  • 现有靶向活检平台包括磁体腔内MR成像靶向活检和实时经直肠超声-MR成像融合活检系统。

核心结论

  • MR成像靶向活检平台包括磁体腔内MR成像靶向活检和实时经直肠超声-MR成像融合活检系统,各技术有其技术考量、优势与挑战。

研究设计与样本

  • 综述,阐述MR成像靶向前列腺活检平台的现状、技术考量及每种技术的优势与挑战。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Systematic transrectal ultrasonography (US)-guided biopsy is the standard approach for histopathologic diagnosis of prostate cancer. However, this technique has multiple limitations because of its inability to accurately visualize and target prostate lesions. Multiparametric magnetic resonance (MR) imaging of the prostate is more reliably able to localize significant prostate cancer. Targeted prostate biopsy by using MR imaging may thus help to reduce false-negative results and improve risk assessment. Several commercial devices are now available for targeted prostate biopsy, including in-gantry MR imaging-targeted biopsy and real-time transrectal US-MR imaging fusion biopsy systems. This article reviews the current status of MR imaging-targeted biopsy platforms, including technical considerations, as well as advantages and challenges of each technique. © RSNA, 2017.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Verma S, Choyke PL, Eberhardt SC, et al. The Current State of MR Imaging-targeted Biopsy Techniques for Detection of Prostate Cancer. Radiology. 2017. PMID: 29045233. doi:10.1148/radiol.2017161684

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。